DiaSorin S.p.A.
DSRLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6 | $5 | $8 | $10 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $6 | $6 | $9 | $11 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 3.2% | -15.6% | 10% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 65.9% | 64.6% | 66.2% | 66.6% |
| EBITDA | $0 | $0 | $0 | $1 |
| % Margin | 33.7% | 29% | 35.2% | 40.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 15.9% | 13.9% | 17.7% | 25.1% |
| EPS Diluted | 3.37 | 2.87 | 4.15 | 5.4 |
| % Growth | 17.4% | -30.8% | -23.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |